Loading
Oncosil Medical Ltd Stock: price and insider trades · Australia
Oncosil Medical Ltd: what insiders have been doing
Oncosil Medical Ltd has a thin disclosure history in our data (latest filing: 11 June 2026). New filings will appear here as soon as they are published. Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 24,090 of 24,148 companies
3.5
score / 100
Value7
Quality0
FCF yld-33%
Earn yld-34%
EV/EBITDA·
ROE-268%
Gross mgn-40%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
A$0.88
Analyst consensus
2.00/5
Income statement
RevenueA$1.7M
Gross profit-A$672.3k-40% margin
EBITDA-A$10.8M-640% margin
Net income-A$10.9M-213.4% margin
Valuation
PER (forward)-0.0x
P/Book5.4x
Beta1.23
Balance sheet & cash
Market capA$32.1M
Total debtA$14.8k
Free Cash Flow-A$10.5M
Debt / Equity0%
Profitability & ownership
ROE-268.2%
ROA-78.8%
% insiders8.7%
% institutions43.7%
Last declaration on 11 June 2026
Declarations1 total
ShareASXISIN AU000000OSL3ASX:2924-03099211-2A1676923
1 of 1 declaration
About Oncosil Medical Ltd
Oncosil Medical Ltd is a company focused on developing cancer treatments, concentrating on innovative therapies. It is listed on the XASX market.
